Phase III trial of AN 2728 in patients with mild-to-moderate plaque-type psoriasis.

Trial Profile

Phase III trial of AN 2728 in patients with mild-to-moderate plaque-type psoriasis.

Not stated
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2012

At a glance

  • Drugs Crisaborole (Primary)
  • Indications Psoriasis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 07 Feb 2012 Planned iniatiation date deferred due to company's intention to focus on development for atopic dermatitis, according to an Anacor Pharmaceuticals media release.
    • 23 Mar 2011 Planned initiation date changed to 1 Dec 2011.
    • 16 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top